329 related articles for article (PubMed ID: 34006679)
1. [Anti-Myelin Oligodendrocyte Glycoprotein Antibody Associated Disease].
Fujimori J; Nakashima I
Brain Nerve; 2021 May; 73(5):483-488. PubMed ID: 34006679
[TBL] [Abstract][Full Text] [Related]
2. Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-Associated CNS Demyelination: Clinical Spectrum and Comparison with Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder.
Ojha PT; Aglave VB; Soni G; Jagiasi KA; Singh RK; Singh RK; Nagendra S
Neurol India; 2020; 68(5):1106-1114. PubMed ID: 33109860
[TBL] [Abstract][Full Text] [Related]
3. [Anti-myelin oligodendrocyte glycoprotein antibody associated encephalitis].
Fujimori J
Rinsho Shinkeigaku; 2020 Feb; 60(2):117-119. PubMed ID: 31956198
[TBL] [Abstract][Full Text] [Related]
4. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
[TBL] [Abstract][Full Text] [Related]
5. Anti-myelin oligodendrocyte glycoprotein antibodies: Magnetic resonance imaging findings in a case series and a literature review.
Cellina M; Fetoni V; Ciocca M; Pirovano M; Oliva G
Neuroradiol J; 2018 Feb; 31(1):69-82. PubMed ID: 28379073
[TBL] [Abstract][Full Text] [Related]
6. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
[TBL] [Abstract][Full Text] [Related]
7. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 3: Brainstem involvement - frequency, presentation and outcome.
Jarius S; Kleiter I; Ruprecht K; Asgari N; Pitarokoili K; Borisow N; Hümmert MW; Trebst C; Pache F; Winkelmann A; Beume LA; Ringelstein M; Stich O; Aktas O; Korporal-Kuhnke M; Schwarz A; Lukas C; Haas J; Fechner K; Buttmann M; Bellmann-Strobl J; Zimmermann H; Brandt AU; Franciotta D; Schanda K; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Nov; 13(1):281. PubMed ID: 27802825
[TBL] [Abstract][Full Text] [Related]
8. MRI findings in pediatric neuromyelitis optica spectrum disorder with MOG antibody: Four cases and review of the literature.
Ikeda A; Watanabe Y; Kaba H; Kaneko K; Takahashi T; Takeshita S
Brain Dev; 2019 Apr; 41(4):367-372. PubMed ID: 30447856
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of children with myelin oligodendrocyte glycoprotein antibody-related disorders.
Konuskan B; Yildirim M; Gocmen R; Okur TD; Polat I; Kilic H; Saltik S; Ozturk Z; Gucuyener K; Altunbasak S; Celik T; Kose G; Yilmaz A; Komur M; Kayilioglu H; Anlar B
Mult Scler Relat Disord; 2018 Nov; 26():1-7. PubMed ID: 30212767
[TBL] [Abstract][Full Text] [Related]
10. Deciphering anti-MOG IgG antibodies: Clinical and radiological spectrum, and comparison of antibody detection assays.
Tzartos JS; Karagiorgou K; Tzanetakos D; Breza M; Evangelopoulos ME; Pelidou SH; Bakirtzis C; Nikolaidis I; Koutsis G; Notas K; Chroni E; Markakis I; Grigoriadis NC; Anagnostouli M; Orologas A; Parisis D; Karapanayiotides T; Papadimitriou D; Kostadima V; Elloul J; Xidakis I; Maris T; Zisimopoulou P; Tzartos S; Kilidireas C
J Neurol Sci; 2020 Mar; 410():116673. PubMed ID: 31954354
[TBL] [Abstract][Full Text] [Related]
11. Anti-myelin oligodendrocyte glycoprotein antibody-positive acute disseminated encephalomyelitis mimicking limbic encephalitis: A case report.
Uchigami H; Arai N; Sekiguchi M; Ogawa A; Yasuda T; Seto A; Takahashi T; Takeuchi S
Mult Scler Relat Disord; 2020 Feb; 38():101500. PubMed ID: 31733424
[TBL] [Abstract][Full Text] [Related]
12. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 2: Epidemiology, clinical presentation, radiological and laboratory features, treatment responses, and long-term outcome.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Ringelstein M; Trebst C; Winkelmann A; Schwarz A; Buttmann M; Zimmermann H; Kuchling J; Franciotta D; Capobianco M; Siebert E; Lukas C; Korporal-Kuhnke M; Haas J; Fechner K; Brandt AU; Schanda K; Aktas O; Paul F; Reindl M; Wildemann B;
J Neuroinflammation; 2016 Sep; 13(1):280. PubMed ID: 27793206
[TBL] [Abstract][Full Text] [Related]
13. MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum Disorder.
Dos Passos GR; Oliveira LM; da Costa BK; Apostolos-Pereira SL; Callegaro D; Fujihara K; Sato DK
Front Neurol; 2018; 9():217. PubMed ID: 29670575
[TBL] [Abstract][Full Text] [Related]
14. Clinical Characteristics and Treatment of MOG-IgG-Associated Optic Neuritis.
Tajfirouz DA; Bhatti MT; Chen JJ
Curr Neurol Neurosci Rep; 2019 Nov; 19(12):100. PubMed ID: 31773369
[TBL] [Abstract][Full Text] [Related]
15. Clinical course, therapeutic responses and outcomes in relapsing MOG antibody-associated demyelination.
Ramanathan S; Mohammad S; Tantsis E; Nguyen TK; Merheb V; Fung VSC; White OB; Broadley S; Lechner-Scott J; Vucic S; Henderson APD; Barnett MH; Reddel SW; Brilot F; Dale RC;
J Neurol Neurosurg Psychiatry; 2018 Feb; 89(2):127-137. PubMed ID: 29142145
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis, Clinical Features, and Treatment of Patients with Myelin Oligodendrocyte Glycoprotein (MOG) Autoantibody-Associated Disorders Focusing on Optic Neuritis with Consideration of Autoantibody-Binding Sites: A Review.
Tanaka K; Kezuka T; Ishikawa H; Tanaka M; Sakimura K; Abe M; Kawamura M
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686172
[TBL] [Abstract][Full Text] [Related]
17. MOG-IgG in NMO and related disorders: a multicenter study of 50 patients. Part 1: Frequency, syndrome specificity, influence of disease activity, long-term course, association with AQP4-IgG, and origin.
Jarius S; Ruprecht K; Kleiter I; Borisow N; Asgari N; Pitarokoili K; Pache F; Stich O; Beume LA; Hümmert MW; Trebst C; Ringelstein M; Aktas O; Winkelmann A; Buttmann M; Schwarz A; Zimmermann H; Brandt AU; Franciotta D; Capobianco M; Kuchling J; Haas J; Korporal-Kuhnke M; Lillevang ST; Fechner K; Schanda K; Paul F; Wildemann B; Reindl M;
J Neuroinflammation; 2016 Sep; 13(1):279. PubMed ID: 27788675
[TBL] [Abstract][Full Text] [Related]
18. Clinical and MRI phenotype of children with MOG antibodies.
Fernandez-Carbonell C; Vargas-Lowy D; Musallam A; Healy B; McLaughlin K; Wucherpfennig KW; Chitnis T
Mult Scler; 2016 Feb; 22(2):174-84. PubMed ID: 26041801
[TBL] [Abstract][Full Text] [Related]
19. Comparison of myelin oligodendrocyte glycoprotein (MOG)-antibody disease and AQP4-IgG-positive neuromyelitis optica spectrum disorder (NMOSD) when they co-exist with anti-NMDA (N-methyl-D-aspartate) receptor encephalitis.
Fan S; Xu Y; Ren H; Guan H; Feng F; Gao X; Ding D; Fang F; Shan G; Guan T; Zhang Y; Dai Y; Yao M; Peng B; Zhu Y; Cui L
Mult Scler Relat Disord; 2018 Feb; 20():144-152. PubMed ID: 29414288
[TBL] [Abstract][Full Text] [Related]
20. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.
Akaishi T; Sato DK; Takahashi T; Nakashima I
Neurochem Int; 2019 Nov; 130():104319. PubMed ID: 30365980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
